Sattva Sukun Lifecare Renames, Reports FY26 Profit Amidst Quarterly Losses

Sattva Sukun Lifecare Limited reported a consolidated profit of ₹0.21 crore for the fiscal year ended March 31, 2026.

Consolidated revenue for FY26 stood at ₹32.25 crore.

Reader Takeaway: Full fund utilization is positive, but Q4 losses are a concern.

What just happened

Sattva Sukun Lifecare Limited, formerly known as Mayukh Dealtrade Limited, has officially changed its name. For the fiscal year 2025-26, the company announced a consolidated profit of ₹0.21 crore on revenues of ₹32.25 crore. Standalone operations reported a profit of ₹0.17 crore on revenues of ₹4.22 crore for the same period. In a separate development, the company completed its rights issue, allotting over 19.16 crore equity shares.

Why this matters

The company confirmed the complete utilization of funds raised through the rights issue. A significant portion, ₹1,168.76 lakh, was invested in its subsidiary, Pavapuri Exports. Funds were also allocated to working capital requirements (₹220.00 lakh), expansion plans like acquiring office space, factory, and land (₹300.00 lakh), general corporate purposes (₹116.16 lakh), and issue-related expenses (₹55.44 lakh).

The backstory

The name change from Mayukh Dealtrade Limited to Sattva Sukun Lifecare Limited signifies a strategic rebranding or restructuring effort. The rights issue and subsequent fund deployment are key to the company's growth strategy, aimed at strengthening its operational base and subsidiary contributions.

What changes now

With the funds fully deployed, investors will expect to see tangible results from the investments in working capital and expansion plans. The performance of the subsidiary, Pavapuri Exports, will be crucial for the consolidated financial health of Sattva Sukun Lifecare.

Risks to watch

A key concern is the net loss reported in the fourth quarter of FY26. Standalone operations posted a loss of ₹0.57 crore, while consolidated operations incurred a loss of ₹0.71 crore. This indicates potential short-term operational challenges or revenue volatility that needs to be addressed.

Auditor Remarks

Sattva Sukun Lifecare's statutory auditors, M/s. SSRV & Associates, have provided an unmodified opinion on the audited financial results, suggesting that the financial statements are presented fairly and without material misstatements.

Investor Takeaway

While the full-year results show a profit, the recent quarterly losses are a point of concern. Investors will be keen to observe if the company can leverage its fully utilized capital for sustained profitable growth and improve its quarterly performance. The successful integration and performance of its subsidiary will also be a key factor.